| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.4M | -40.3% |
| Cost of Revenue | $21.9M | -36.0% |
| Gross Profit | $21.5M | -44.1% |
| R&D Expense | $7.0M | -26.1% |
| SG&A Expense | $9.9M | -25.4% |
| Operating Income | -$3.6M | -163.5% |
| Pre-tax Income | -$3.6M | -160.4% |
| Income Tax | $6.3M | +445.0% |
| Net Income | -$9.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.4M | +16.8% |
| Accounts Receivable | $6.5M | -33.8% |
| Inventory | $16.2M | -9.0% |
| Current Assets | $38.4M | -6.4% |
| Total Assets | $44.0M | -18.8% |
| Current Liabilities | $12.9M | -5.5% |
| Total Liabilities | $13.4M | -9.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.9M | -66.2% |
| Capital Expenditures | $322K | -64.3% |
| Investing Cash Flow | -$322K | +64.3% |
| Financing Cash Flow | $634K | +828.7% |
| Free Cash Flow | $1.5M | -66.6% |
| -307.7% |
| EPS (Basic) | -$0.99 | -306.3% |
| EPS (Diluted) | -$0.99 | -310.6% |
| Stockholders' Equity |
| $30.6M |
| -22.3% |